B. Riley Wealth Advisors’s Editas Medicine EDIT Stock Holding History

B. Riley Wealth Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,760	Closed	-$132K	–	1514
2022 Q3	$132K	Buy	+10,760	New	+$168K	﹤0.01%	1294
2022 Q1	–	Sell	-10,012	Closed	-$266K	–	1422
2021 Q4	$266K	Sell	10,012 -55	-0.5%	-$1.89K	0.01%	1137
2021 Q3	$414K	Buy	10,067 +15	+0.1%	+$822	0.01%	877
2021 Q2	$570K	Buy	10,052 +1,285	+15%	+$47.5K	0.02%	702
2021 Q1	$369K	Buy	8,767 +2,880	+49%	+$164K	0.01%	885
2020 Q4	$413K	Buy	+5,887	New	+$242K	0.02%	602

Other funds holding EDIT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

B. Riley Wealth Advisors's EDIT Position: Q4 2022 in Review

B. Riley Wealth Advisors sold out of Editas Medicine (EDIT) in Q4 2022, closing a stake of 10,760 shares — an estimated $132K sold.

B. Riley Wealth Advisors first reported a position in EDIT in Q4 2020 and held it in 6 quarters. The position peaked at $570K in Q2 2021. 250 funds tracked by Wall St. Rank hold EDIT as of Q4 2022.

B. Riley Wealth Advisors reported no remaining Editas Medicine position as of Q4 2022 after selling out during the quarter.
B. Riley Wealth Advisors sold 10,760 Editas Medicine shares in Q4 2022, an estimated $132K.
B. Riley Wealth Advisors first reported a position in Editas Medicine in Q4 2020 and held it in 6 quarters.
B. Riley Wealth Advisors's Editas Medicine position peaked at $570K in Q2 2021.
250 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2022.

Based on B. Riley Wealth Advisors's 13F filing for Q4 2022, filed 21 Feb 2023.